Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
August 2003
2003:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2004 | 2005 | 2006 | 2007 | 2008
News | News in brief | News Features
News
Quest for SARS source gathers pace in bid to thwart resurgence
At least three species of wild animals sold in markets in the Guangdong province of southern China have been shown to harbour the virus that causes severe acute respiratory syndrome (SARS).
Nature (28 August 2003)
| Full Text |
Business backlash kills off software meeting
Lobbying by US business interests has shot down a proposed meeting, to be held by the Geneva-based World Intellectual Property Organization (WIPO) next year, to explore 'open' models of innovation.
Nature (28 August 2003)
| Full Text |
Biophysicist named to run basic-research arm of NI
The US National Institute of General Medical Sciences (NIGMS) — the arm of the National Institutes of Health that focuses on basic research — has named its next director.
Nature (28 August 2003)
| Full Text |
Postdocs show independent spirit
Establishing just the right degree of independence is critical to forging successful relationships between postdoctoral fellows and their mentors, according to a survey at the US National Institutes of Health (NIH).
Nature (28 August 2003)
| Full Text |
Bioweapons initiatives bogged down in talks
Bioweapons experts convene in Geneva, Switzerland, this week for fresh talks on the Biological Weapons Convention, the international treaty that seeks to counter the proliferation of such weapons.
Nature (21 August 2003)
| Full Text |
Accrued HIV evidence turns treatment dogma on its head
A series of studies has dispelled the widespread notion that patients who don't take every dose of their anti-HIV medication create a public-health risk by helping to nurture HIV strains that resist therapy.
Nature (21 August 2003)
| Full Text |
Chinese fusion method promises fresh route to human stem cells
Biologists in China have reprogrammed human cells by fusing them with rabbit eggs emptied of their genetic material. And they have extracted stem cells, which have the potential to form a wide array of different cell types, from the resulting embryos.
Nature (14 August 2003)
| Full Text |
Bush accused of power abuse over science
A prominent Congressman has accused the Bush administration of interfering with US science to such an extent that it is threatening public trust in both science and government.
Nature (14 August 2003)
| Full Text |
Fast vaccine offers hope in battle with Ebola
High-speed vaccines could help to contain unexpected outbreaks of disease, say US researchers who have developed a fast-acting vaccine against the deadly Ebola virus.
Nature (7 August 2003)
| Full Text |
Czech stem-cell work heightens calls for EU ruling
Czech scientists say they have derived three human embryonic stem-cell lines from spare embryos stored at an in vitro fertilization clinic in Brno.
Nature (7 August 2003)
| Full Text |
WHO prepares for final push to rid the world of polio
With the fight against polio close to being won, the newly appointed director-general of the World Health Organization, Lee Jong-wook, announced on 29 July that eradication of the disease by 2005 is one of his top priorities.
Nature (7 August 2003)
| Full Text |
Red tape frustrates Europe's fund-seekers
August 2003 Scientists who burnt the midnight oil for months to apply for the first round of funding under the European Union's new Framework research programme are angry about the complex bureaucracy they were forced to endure.
Nature (7 August 2003)
| Full Text |
Companies vie to put all your genes on a chip
The race is on to produce a commercial DNA microarray that covers the whole human genome
Nature (7 August 2003)
| Full Text |
Expert panel retreats from major restructuring in blueprint for NIH
The US National Institutes of Health (NIH) should be reorganized so that it can support high-risk, pathfinding research more effectively, says an eminent group of scientists and public-policy experts in what is likely to be an influential report.
Nature (31 July 2003)
| Full Text |
US researchers fear job losses from privatization drive
US scientists have reacted anxiously to a government plan to contract out federal scientific projects, citing fears that the scheme could damage research.
Nature (31 July 2003)
| Full Text |
Proteomics delivers on promise of cancer biomarkers
Hot on the trail of cancer biomarkers—telltale proteins in body fluids that can expose a malignant tumor—researchers are using the latest in proteomics techniques.
Nature Medicine (August 2003)
| Full Text |
Spain's scientists granted new career choice
Spain's health ministry in July approved unprecedented reforms, allowing its medical residents to become full-time researchers after completing their residency.
Nature Medicine (August 2003)
| Full Text |
'Emancipated' biotechs offer new drugs for neurodegeneration
Six new drugs for the rare neurodegenerative disease amyotrophic lateral sclerosis (ALS) are poised to enter clinical trials this fall, of which two are products of a tiny, young nonprofit biotechnology company.
Nature Medicine (August 2003)
| Full Text |
Technology, tradition unite in India's drug discovery scheme
India has embarked on a fast-track program to discover new drugs by building on traditional medicines and screening the country's diverse plant and microbial resources.
Nature Medicine (August 2003)
| Full Text |
Japan launches controversial Biobank project
Japan is pushing ahead with a new five-year, $180 million project to build a bio-repository of blood and tissue samples from 300,000 citizens suffering from cancers, diabetes, rheumatoid arthritis and other common diseases.
Nature (17 July 2003)
| Full Text |
US courts narrow patent exemptions
In June, the US Court of Appeals for the Federal Circuit issued a ruling in a patent infringement lawsuit that is being praised as a victory for biotechnology companies and researchers holding patents protecting their research tool inventions.
Nature Biotechnology (August 2003)
| Full Text |
Illumina tussles in court with ABI
An ongoing legal battle between Applied Biosystems and Illumina , concerning an unfruitful collaboration struck in 1999 to build a genotyping system to identify single DNA base-pair changes, is set to hit the courtroom on August 22.
Nature Biotechnology (August 2003)
| Full Text |
US government previews biotech survey
The US Department of Commerce recently offered a sneak preview of the results from its first survey of biotechnology activities in the United States.
Nature Biotechnology (August 2003)
| Full Text |
News in brief
Wave of controversies spurs probe into fair presentation of results
| Head of Australian stem-cell centre quits to return to science
| Open-access trial next step in biology journal's life cycle
| Traditional values for transatlantic venture
| US neuroscience institute fills directorship at last
| Australia beefs up an udder genome project | All change at the top for French research | Row over junk DNA patents comes home to Australia
| NIH's summer of scandal
| Europe to donate a billion dollars to Global Fund
| Massive cancer study set to probe epidemiologic trends
| US to speed up drug review
| US FDA approves Xolair
| Bush and McClellan speak at BIO convention
| Stem cell consortium
| Large projects in vogue
| Death knell for PPL?
|
News Features
Cell culture: Biology's new dimension
There's a big difference between a flat layer of cells and a complex, three-dimensional tissue. But until recently, many biologists have glossed over this fact.
Nature (21 August 2003)
| Full Text |
Lab architecture: Do you want to work here?
The architects behind a new generation of laboratories believe their designs can stimulate good science. Laura Bonetta finds out how, and looks at research that may one day help to test their claims.
Nature (14 August 2003)
| Full Text |
DNA microarrays: Vital statistics
DNA microarrays have given geneticists and molecular biologists access to more data than ever before. But do these researchers have the statistical know-how to cope?
Nature (07 August 2003)
| Full Text |
|
